Wow, a drug to target an even bigger market than the first one. This company now no longer a one hit wonder. I like the fact that the second drug piggy backs off the process of the first reducing the time in development. The first time we have seen value in the platform poke its nose up. This might awaken the interests of another group of people.
Ann: Second Potential Blockbuster Drug Added to PYC's Pipeline, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.020(1.77%) |
Mkt cap ! $670.7M | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.18 | $1.11 | $172.3K | 151.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 592 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 4211 | 1 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |